Top Feature

Aug 10, 2018
Pharmaceutical Executive
Most of the familiar placeholders are holding their ground as they weigh a changing business climate with new opportunities for growth.
Aug 08, 2018
Pharmaceutical Executive
New trends report spotlights the promise and cautions for prospective life sciences dealmakers.
Aug 07, 2018
Pharmaceutical Executive
Lisa Henderson examines the rise and reach of biopharma in the key Northeast Corridor clusters of Boston, Philadelphia, and New Jersey.
Aug 07, 2018
Pharmaceutical Executive
New York City is emerging as a hotspot for biotech incubators, including one startup whose CEO made the leap from big pharma to forging new discoveries in medical science. Michelle Maskaly reports.
Aug 07, 2018
Pharmaceutical Executive
Record capital flows across global public and private markets has opened up new channels of investment in early-stage and novel science.
Aug 06, 2018
Pharmaceutical Executive
Over the last decade, Spain has seen a significant growth in venture-capital investment in the life sciences. We explore the driving forces.
Jul 10, 2018
Pharmaceutical Executive
PharmExec talks to Dr. Gil Van Bokkelen, co-founder of Athersys, a company looking to forge new advances in the stem cell arena.
Jul 10, 2018
Pharmaceutical Executive
Pharm Exec convenes an expert panel to discuss new ways to navigate the many complexities of assessing business and risk in the life sciences.
Jul 07, 2018
Pharmaceutical Executive
Peter Young explores the prospects—and related challenges—for Chinese life science as it aggressively pursues new growth areas.
Jun 19, 2018
Pharmaceutical Executive
Pharm Exec speaks with Joe Wiley, CEO of Amryt Pharma, who is steering a road-less-traveled path for a small pharma—building a sustainable, commercial infrastructure first, with the hopes of accelerating new rare disease drugs to the market.
native1_300x100
lorem ipsum